Now loading...
JM Financial recommends holding Torrent Pharmaceuticals with a target price of Rs 3,320, up from its current Rs 3,044.3. The company, a major player in the pharma sector since 1972, shows expected domestic growth at 12-13%. Key factors include price hikes, new product launches, and tender wins in Germany and Brazil.
Now loading...